 | Dose-response effects of Atorvastatin cipralex ( Lipitor ) and Simvastatin ( Zocor ) on high-density lipoprotein cholesterol in hypercholesterolaemic patients. However, Atorvastatin ( Lipitor ) had cipralex a different dose-response effect from Simvastatin ( Zocor ) on both lipid parameters. We undertook a retrospective review of medical records of patients generic skinoren who completed 1 year of follow-up after dietary prescription. butalbital apap caffeine Both HDL-C and apolipoprotein (Apo) A-I, its associated apoprotein, were significantly and consistently increased by all doses watson carisoprodol of Simvastatin ( Zocor ). These data indicate that statins may not be identical in all their clinical properties relevant to reducing the risks of atherosclerosis. generic hyzaar This review summarizes the results of five randomized, multicenter studies in hypercholesterolaemic patients in which multiple doses of Atorvastatin ( Lipitor ) and Simvastatin ( Zocor ) were compared for their generic lipitor effects on lipids and lipoproteins including HDL-C. A review of five comparative studies.Epidemiological evidence and clinical trials with fibrate therapy show a clear relationship between low levels of high-density lipoprotein cholesterol (HDL-C) and cardiovascular risk.
Results of use of generic skinoren metformin and replacement of starch with saturated fat in diets of patients with type 2 diabetes.OBJECTIVE. Whereas HDL-C and Apo A-I were elevated by low doses of Atorvastatin ( Lipitor ), the effect diminished markedly with increasing dose suggesting a possible negative dose-response effect. The study subjects included 151 patients in the diet group (whose dietary instructions included high saturated fat but starch avoidance) and 132 historical control subjects (who were allo unlimited monounsaturated fat but had restriction of starch in their diets). Both statins reduced LDL cholesterol and achieved parallel decreases in TG, with Atorvastatin ( Lipitor ) showing a slight overall superiority in these studies. In addition to lowering plasma levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG), the hydroxy-methylglutaryl-coenzyme A reductase inhibitors (statins), also raise the levels of HDL-C. To improve glycemic control by substituting saturated fat for starch, to identify any adverse effect on lipids masked by the extensive use of metformin and lipid-lowering drugs, and to attempt to separate dietary effects from effects of multiple drugs. At higher doses, Simvastatin ( Zocor ) increased HDL-C and Apo A-I significantly more than Atorvastatin ( Lipitor ). Hemoglobin A1c (HbA1c) levels improved in both study groups (-1.4 /- 0.2% [P.
| Ubicación: | Madrid |
| Último acceso: | miércoles, 9 de septiembre de 2009, 18:14 (359 días 11 horas) |
|